STVN logo

Stevanato Group SpA (STVN)

Profile

Full Name

Stevanato Group S.p.A.

Ticker Symbol

STVN

Exchange

NYSE

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

Italy

IPO

July 16, 2021

Indexes

Not included

Website

http://www.stevanatogroup.com

Employees

5521

Key Details

Price

$22.08(-2.47%)

Market cap

$6.03B(Mid cap)

Last Dividend

$0.06

TTM Dividend yield

0.26%

Annual revenue

$1.19B(+1.70% YoY)

Annual EPS

$0.47(-21.83% YoY)

PE ratio

46.48

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$22.08
STVN price is $22.08

30-Day Relative Volume

0.54
STVN 30-day relative volume is 0.54

Price Performance

Price Today change

-2.47%
STVN price is down -2.47% today

Price YTD change

+1.33%
STVN price is up +1.33% since January 1st

Price 1-year change

-23.78%
STVN price is down -23.78% year-on-year

Price 3-year change

+10.73%
STVN price is up +10.73% over the past 3 years

Price Range

Price All-time high

$36.30
STVN price is currently -39.17% below its historical high of $36.30

Price 3-year low

$13.36
STVN price is currently +65.33% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$6.03B
STVN market capitalization is $6.03 billion

Market cap 3-year change

+14.16%
STVN market capitalization is up +14.16% over the past 3 years

Market cap All-time high

$9.39B
STVN market capitalization is currently -35.86% below its historical high of $9.39 billion

Market cap sector rank

90.3%
STVN market capitalization is higher than 90.3% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.05%
STVN shares outstanding is up +0.05% year-on-year

Shares Outstanding 3-Year Change

+3.1%
STVN shares outstanding is up +3.1% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.60
STVN beta is 0.60

200-day SMA

$20.48
STVN price is currently +7.79% above its 200-day simple moving average

50-day SMA

$20.68
STVN price is currently +6.75% above its 50-day simple moving average

RSI

57.29
STVN 14-day relative strength index is 57.29

Volume

0.54
STVN 30-day relative volume is 0.54

ATR

$1.40
STVN average true range is $1.40

10-day Historical Volatility

79.50%
STVN 10-day historical volatility is 79.50%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.06
STVN last dividend was $0.06 per share, with an ex-dividend date of June 4, 2024

Next Dividend

-
STVN next dividend has not yet been announced

Dividend per share

Dividend per share

$0.06
STVN annual dividend per share is $0.06

Dividend per share Sector Rank

1.16%
STVN annual dividend per share is higher than 1.16% of companies in Healthcare sector

Dividend per share 1-Year Change

0%
STVN {parameterFullLabel} has remained unchanged year-on-year

Dividend per share 3-Year Change

-
STVN annual dividend per share 3-year change is unknown

Dividend yield

Dividend yield

0.26%
STVN annual dividend yield is 0.26%

Dividend yield Sector Rank

2.35%
STVN annual dividend yield is higher than 2.35% of companies in Healthcare sector

Other

Payout ratio

12.27%
STVN annual payout ratio is 12.27%

Dividends paid

$15.65M
STVN annual dividends paid is $15.65 million

Free cash flow

-$170.79M
STVN annual free cash flow is -$170.79 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$1.19B
STVN annual revenue is $1.19 billion

Revenue Analysts estimate

$1.17B
STVN annual revenue is currently +1.71% higher than the consensus analysts' forecast

Revenue 1-year change

+1.7%
STVN annual revenue is up +1.7% year-on-year

Revenue Sector rank

81.9%
STVN annual revenue is higher than 81.9% of companies in Healthcare sector

EPS

EPS

$0.47
STVN annual earnings per share is $0.47

EPS Analysts estimate

$0.58
STVN annual earnings per share is currently -20.06% lower than the consensus analysts' forecast

EPS 1-year change

-21.83%
STVN annual earnings per share is down -21.83% year-on-year

EPS Sector rank

86.91%
STVN annual earnings per share is higher than 86.91% of companies in Healthcare sector

Profit

Gross profit

$327.21M
STVN annual gross profit is $327.21 million

Gross margin

27.38%
STVN annual gross profit margin is 27.38%

Operating profit

$174.41M
STVN annual operating income is $174.41 million

Operating margin

14.60%
STVN annual operating profit margin is 14.60%

Net income

$127.48M
STVN annual net profit is $127.48 million

Net margin

10.67%
STVN annual net profit margin is 10.67%

Expenses

Total expenses

$1.02B
STVN annual total expenses is $1.02 billion

Operating expenses

$152.80M
STVN annual total operating expenses is $152.80 million

Cost of goods sold

$867.74M
STVN annual cost of goods sold is $867.74 million

Selling, general & administrative expenses

$128.37M
STVN annual SGA is $128.37 million

Depreciation and amortization

$87.29M
STVN annual depreciation & amortization is $87.29 million

Interest expense

$7.43M
STVN annual interest expense is $7.43 million

Income tax

$46.02M
STVN annual income tax is $46.02 million

EBIT & EBITDA

EBIT

$180.92M
STVN annual earnings before interest & taxes is $180.92 million

EBITDA

$268.21M
STVN annual EBITDA is $268.21 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$2.42B
STVN annual total assets is $2.42 billion

Non current assets

$1.51B
STVN annual long term assets is $1.51 billion

Current assets

$915.83M
STVN annual total current assets is $915.83 million

Cash and cash equivalents

$102.26M
STVN annual cash & cash equivalents is $102.26 million

Accounts receivable

$307.96M
STVN annual accounts receivable is $307.96 million

Inventory

$255.17M
STVN annual inventory is $255.17 million

Liabilities

Total liabilities

$961.94M
STVN annual total liabilities is $961.94 million

Long term liabilities

$465.09M
STVN annual total long term liabilities is $465.09 million

Current liabilities

$496.85M
STVN annual total current liabilities is $496.85 million

Accounts payable

$240.39M
STVN annual accounts payable is $240.39 million

Debt

Total debt

$446.37M
STVN annual total debt is $446.37 million

Total debt 1-year change

+1.82%
STVN annual total debt is up +1.82% year-on-year

Long term debt

$329.90M
STVN annual long term debt is $329.90 million

Short term debt

$116.48M
STVN annual short term debt is $116.48 million

Equity & Capital

Shareholders equity

$1.46B
STVN annual stockholders equity is $1.46 billion

Book value

$1.46B
STVN annual book value is $1.46 billion

Retained earnings

$898.47M
STVN annual retained earnings is $898.47 million

Working capital

$418.98M
STVN annual working capital is $418.98 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$168.60M
STVN annual cash flow from operations is $168.60 million

Cash from operations 1-year change

+48.03%
STVN annual cash flow from operations is up +48.03% year-on-year

Cash from investing

-$335.76M
STVN annual cash flow from investing activities is -$335.76 million

Cash from investing 1-year change

+26.37%
STVN annual cash flow from investing activities is up +26.37% year-on-year

Cash from financing

$198.31M
STVN annual cash flow from financing activities is $198.31 million

Cash from financing 1-year change

+15.91%
STVN annual cash flow from financing activities is up +15.91% year-on-year

CAPEX

CAPEX

$339.39M
STVN annual capital expenditures is $339.39 million

CAPEX 1-year change

-29.06%
STVN annual capital expenditures is down -29.06% year-on-year

Free Cash Flow

Free cash flow

-$170.79M
STVN annual free cash flow is -$170.79 million

Free cash flow 1-year change

+53.15%
STVN annual free cash flow is up +53.15% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

27.38%
STVN annual gross profit margin is 27.38%

Operating margin

14.60%
STVN annual operating profit margin is 14.60%

Net margin

10.67%
STVN annual net profit margin is 10.67%

ROA & ROE

ROA

5.41%
STVN annual return on assets is 5.41%

ROE

9.40%
STVN annual return on equity is 9.40%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

46.48
STVN price to earnings ratio is 46.48

PE ratio Sector rank

77.45%
STVN price to earnings ratio is higher than 77.45% of companies in Healthcare sector

PB Ratio

PB ratio

4.12
STVN price to book ratio is 4.12

PB ratio Sector rank

80%
STVN price to book ratio is higher than 80% of companies in Healthcare sector

PS Ratio

PS ratio

5.05
STVN price to sales ratio is 5.05

PS ratio Sector rank

66.03%
STVN price to sales ratio is higher than 66.03% of companies in Healthcare sector

Enterprise value

Enterprise value

$6.37B
STVN enterprise value is $6.37 billion

Enterprise value Sector rank

89.58%
STVN enterprise value is higher than 89.58% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

21.70
STVN EV/EBITDA is 21.70

EV/EBITDA Sector rank

92.6%
STVN EV/EBITDA is higher than 92.6% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.84
STVN annual current ratio is 1.84

Quick ratio

1.33
STVN annual quick ratio is 1.33

Leverage

Debt to equity

0.29
STVN annual debt to equity ratio is 0.29

Interest coverage ratio

24.35
STVN annual interest coverage ratio is 24.35

Risk & Stability

Piotroski F-Score

5
STVN piotroski f-score is 5

Altman Z-Score

5.22
STVN altman z-score is 5.22

Analyst ratings

Recent major analysts updates

Mar 7, 25 UBS
Neutral
Dec 13, 24 Wolfe Research
Outperform
Dec 13, 24 B of A Securities
Buy
Aug 7, 24 Citigroup
Buy
Jul 15, 24 Morgan Stanley
Equal-Weight
Apr 22, 24 Morgan Stanley
Equal-Weight
Mar 25, 24 Stephens & Co.
Overweight
Nov 1, 23 Morgan Stanley
Equal-Weight
Nov 1, 23 Jefferies
Hold
Sep 26, 23 Stephens & Co.
Overweight

Institutional Ownership

Similar stocks

LEGN logo
Legend Biotech (LEGN)
TGTX logo
TG Therapeutics (TGTX)
JAZZ logo
Jazz Pharmaceuticals (JAZZ)
WAY logo
Waystar Holding (WAY)
TFX logo
Teleflex Incorporated (TFX)
BBIO logo
BridgeBio Pharma (BBIO)
BRKR logo
Bruker (BRKR)
Telix Pharmaceuticals Limited (TLX)
RVMD logo
Revolution Medicines (RVMD)
  • What is the ticker symbol for Stevanato Group SpA?
  • Does Stevanato Group SpA pay dividends?
  • What sector is Stevanato Group SpA in?
  • What industry is Stevanato Group SpA in?
  • What country is Stevanato Group SpA based in?
  • When did Stevanato Group SpA go public?
  • Is Stevanato Group SpA in the S&P 500?
  • Is Stevanato Group SpA in the NASDAQ 100?
  • Is Stevanato Group SpA in the Dow Jones?
  • When was Stevanato Group SpA's last earnings report?
  • When does Stevanato Group SpA report earnings?

What is the ticker symbol for Stevanato Group SpA?

The ticker symbol for Stevanato Group SpA is NYSE:STVN

Does Stevanato Group SpA pay dividends?

Yes, Stevanato Group SpA pays dividends. The last payment was $0.06, with an ex-dividend date on June 4, 2024

What sector is Stevanato Group SpA in?

Stevanato Group SpA is in the Healthcare sector

What industry is Stevanato Group SpA in?

Stevanato Group SpA is in the Medical Instruments & Supplies industry

What country is Stevanato Group SpA based in?

Stevanato Group SpA is headquartered in Italy

When did Stevanato Group SpA go public?

Stevanato Group SpA's initial public offering (IPO) was on July 16, 2021

Is Stevanato Group SpA in the S&P 500?

No, Stevanato Group SpA is not included in the S&P 500 index

Is Stevanato Group SpA in the NASDAQ 100?

No, Stevanato Group SpA is not included in the NASDAQ 100 index

Is Stevanato Group SpA in the Dow Jones?

No, Stevanato Group SpA is not included in the Dow Jones index

When was Stevanato Group SpA's last earnings report?

Stevanato Group SpA's most recent earnings report was on Mar 6, 2025

When does Stevanato Group SpA report earnings?

The next expected earnings date for Stevanato Group SpA is May 9, 2025
On this page